Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit
Standard
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. / Heil, J; Gondos, A; Rauch, G; Marmé, F; Rom, J; Golatta, M; Junkermann, H; Sinn, P; Aulmann, S; Debus, J; Hof, H; Schütz, F; Brenner, H; Sohn, C; Schneeweiss, A.
In: BREAST, Vol. 21, No. 3, 06.2012, p. 303-308.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit
AU - Heil, J
AU - Gondos, A
AU - Rauch, G
AU - Marmé, F
AU - Rom, J
AU - Golatta, M
AU - Junkermann, H
AU - Sinn, P
AU - Aulmann, S
AU - Debus, J
AU - Hof, H
AU - Schütz, F
AU - Brenner, H
AU - Sohn, C
AU - Schneeweiss, A
N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.
PY - 2012/6
Y1 - 2012/6
N2 - INTRODUCTION: Evaluation of oncological outcome and prognostic factors of patients with primary breast cancer treated at a certified academic breast unit.PATIENTS AND METHODS: We prospectively collected data of 3338 patients, diagnosed with primary breast cancer between 01.01.2003 and 31.12.2010 and treated at the Breast Unit Heidelberg, Germany, in order to analyze outcome in clinical practice. We evaluated local control rate (LCR), disease-free survival (DFS), distant disease-free survival (DDFS), observed overall survival (OS) and age-adjusted relative overall survival (ROS). In addition, the impact of known prognostic factors on these outcome variables was examined in univariate and multivariate analyses.RESULTS: Of all patients, 368 (11.0%) had carcinoma in situ (CIS) and 197 (5.9%) had bilateral cancers. For the 2970 patients with invasive cancer, of which 49 patients (1.7%) had metastastic disease at time of diagnosis, DFS, LCR, DDFS, OS and ROS at 5 years were 79.8%, 84.7%, 81.2%, 86.3%, and 89.8%, respectively. In multivariate analysis age, pT category, nodal status, hormone receptor status and grading were identified as independent prognostic factors for OS.CONCLUSION: Compared with recent population-based reports from Germany, more favourable patient characteristics and nominally higher survival was found among this large cohort of patients with primary breast cancer treated at a single certified breast unit.
AB - INTRODUCTION: Evaluation of oncological outcome and prognostic factors of patients with primary breast cancer treated at a certified academic breast unit.PATIENTS AND METHODS: We prospectively collected data of 3338 patients, diagnosed with primary breast cancer between 01.01.2003 and 31.12.2010 and treated at the Breast Unit Heidelberg, Germany, in order to analyze outcome in clinical practice. We evaluated local control rate (LCR), disease-free survival (DFS), distant disease-free survival (DDFS), observed overall survival (OS) and age-adjusted relative overall survival (ROS). In addition, the impact of known prognostic factors on these outcome variables was examined in univariate and multivariate analyses.RESULTS: Of all patients, 368 (11.0%) had carcinoma in situ (CIS) and 197 (5.9%) had bilateral cancers. For the 2970 patients with invasive cancer, of which 49 patients (1.7%) had metastastic disease at time of diagnosis, DFS, LCR, DDFS, OS and ROS at 5 years were 79.8%, 84.7%, 81.2%, 86.3%, and 89.8%, respectively. In multivariate analysis age, pT category, nodal status, hormone receptor status and grading were identified as independent prognostic factors for OS.CONCLUSION: Compared with recent population-based reports from Germany, more favourable patient characteristics and nominally higher survival was found among this large cohort of patients with primary breast cancer treated at a single certified breast unit.
KW - Academic Medical Centers
KW - Adult
KW - Age Factors
KW - Antineoplastic Combined Chemotherapy Protocols
KW - Breast Neoplasms
KW - Carcinoma
KW - Chemotherapy, Adjuvant
KW - Combined Modality Therapy
KW - Disease-Free Survival
KW - Female
KW - Germany
KW - Humans
KW - Middle Aged
KW - Prognosis
KW - Prospective Studies
KW - Radiotherapy, Adjuvant
KW - Survival Rate
KW - Treatment Outcome
KW - Women's Health
KW - Young Adult
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1016/j.breast.2012.01.009
DO - 10.1016/j.breast.2012.01.009
M3 - SCORING: Journal article
C2 - 22310244
VL - 21
SP - 303
EP - 308
JO - BREAST
JF - BREAST
SN - 0960-9776
IS - 3
ER -